Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Non-Current Deffered Revenue (2016 - 2025)

Sensus Healthcare has reported Non-Current Deffered Revenue over the past 10 years, most recently at $10000.0 for Q4 2025.

  • Quarterly results put Non-Current Deffered Revenue at $10000.0 for Q4 2025, down 81.82% from a year ago — trailing twelve months through Dec 2025 was $10000.0 (down 81.82% YoY), and the annual figure for FY2025 was $10000.0, down 81.82%.
  • Non-Current Deffered Revenue for Q4 2025 was $10000.0 at Sensus Healthcare, down from $21000.0 in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for SRTS hit a ceiling of $418000.0 in Q1 2021 and a floor of $10000.0 in Q4 2025.
  • Median Non-Current Deffered Revenue over the past 5 years was $98000.0 (2023), compared with a mean of $135950.0.
  • Peak annual rise in Non-Current Deffered Revenue hit 7.5% in 2025, while the deepest fall reached 81.82% in 2025.
  • Sensus Healthcare's Non-Current Deffered Revenue stood at $262000.0 in 2021, then plummeted by 46.95% to $139000.0 in 2022, then tumbled by 56.83% to $60000.0 in 2023, then decreased by 8.33% to $55000.0 in 2024, then plummeted by 81.82% to $10000.0 in 2025.
  • The last three reported values for Non-Current Deffered Revenue were $10000.0 (Q4 2025), $21000.0 (Q3 2025), and $32000.0 (Q2 2025) per Business Quant data.